Glenmark Pharmaceuticals Ltd (GLENMARK) — Voting Results | 11 September 2026
Glenmark Pharmaceuticals held its 48th AGM on September 11, 2026 via video conference, approving audited standalone and consolidated financial statements for FY2025-26, declaring a dividend of Rs. 2.50 per share, reappointing Mrs. Blanche Saldanha as a Non-Executive Director, and ratifying the Cost Auditor's remuneration for FY2026-27. Shareholders cast votes electronically through NSDL, with results showing overwhelming approval across all resolutions. The meeting concluded at 3:51 p.m. after a 30-minute post-AGM e-voting window.
About Glenmark Pharmaceuticals Ltd (GLENMARK)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when GLENMARK files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GLENMARK — Free💡 Ask AI about this filing
📊 More GLENMARK filings
- Announcement — 20 August 2026 Glenmark Pharmaceuticals announced U.S. FDA approval for its generic Fluticasone Propionate Nasal Sp...
- 🟡 Board Meeting — 13 August 2026 Glenmark Pharmaceuticals announced its 48th AGM on September 11, 2026, via video conferencing, where...
- 🔴 Annual Report — 13 August 2026 Glenmark Pharmaceuticals disclosed on August 13, 2026 that shareholders without registered email add...
- Announcement — 11 August 2026 Glenmark Pharmaceuticals disclosed a settlement agreement with Humana to resolve U.S. antitrust liti...
- 🔴 Corporate Action — 10 August 2026 Glenmark Pharmaceuticals allotted 23,863 equity shares of Re. 1 each on August 10, 2026, under its E...
🔥 Also filed on 11 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GLENMARK files new disclosures
Track GLENMARK filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GLENMARK — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd